LeMaitre Vascular, Inc.LMAT
Health Care · Health Care Equipment & Services · NASDAQ · United States · lemaitre.com
LeMaitre Vascular designs, manufactures and sells medical devices and implants used in the treatment of peripheral vascular disease, including grafts, valvulotomes, shunts and patches for vascular surgeons. Based in Burlington, Massachusetts, it sells worldwide through a direct sales force.
Key ratios
Operating cash flow growth
41.2%TTM
2025
84.1%2024
20.1%2023
44.8%
EPS growth
39.4%TTM
2025
30.6%2024
44.0%2023
44.1%
FCF / Sales
29.8%2025
2024
16.9%2023
15.2%
Net margin
25.0%TTM
2025
23.1%2024
20.0%2023
15.6%
ROA
7.4%TTM
2025
6.8%2024
7.3%2023
7.1%
ROE
16.8%TTM
2025
15.8%2024
13.9%2023
10.6%
Revenue growth
11.9%TTM
2025
13.5%2024
13.6%2023
19.7%
Track LMAT in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer